Float, the marketplace moving all the care that doesn’t need a hospital to the home, has officially announced the launch of significant updates for its proprietary AI-powered platform, including the company’s nurse mobile app and specialty pharmacy portal.
In case you weren’t aware, the stated Float platform has been markedly designed around the principles of AI to clock stronger joint outcomes across chronic illness patients, nurses, and pharmacies. These outcomes include matching chronic illness patients with experienced local nurses in minutes, consolidating structured and unstructured patient data for nurses and pharmacies to access easily, and auto-scheduling critical patient visits.
Not just that, the solution in question also treads up a long distance to provide pharmacies with performance metrics that can optimize their operations and automate document creation, including patient charts and prescriptions requiring doctor sign-off.
Anyway, talk about Float’s newly-launched enhancements on a slightly deeper level, they begin from the updated nurse mobile app, which now offers you the facility to receive and accept home infusion offers, review clinical details for patients, manage schedules, see upcoming payments, and engage with Float’s Learning Management Software (LMS) for upskilling opportunities.
Complementing these offerings is the fact that Float regularly collects nurse feedback to inform interface updates, boosting overall satisfaction and retention.
Next up, we have an updated specialty pharmacy portal, which will make it possible for pharmacies, moving forward, to secure nurses for patient home visits within minutes. Furthermore, pharmacy teams can seamlessly use the portal to view patient visit schedules, monitor treatment progression, and supply medication accordingly.
All in all, by centralizing the relevant information in one place, Float promises to eliminate a large part of the administrative burden associated with outdated practices.
Then, there is the sponsorship of waypoints. This translates to an open-source career development framework which is designed to encourage engineers to place the real-world impact of their code at the forefront of their work, a critical component missing from most healthcare technologies.
The development in question delivers a rather interesting follow-up to all what Float achieved during 2024, including a $10M Series A funding round and expanded operations across California, Arizona, and Texas,
Upon breaking down these milestones into specific components, we would come to know that the company also completed more than 45,000 home visits. You see, going by the current run rate, Float completes over 3,000 home visits per month, thus showcasing the substantial value it provides to nurses, patients, prescribers, pharmacies, payers, and hospitals.
As for the future, the company is hoping to hit 8,000 home visits per month by Q1 2026.
Moving on, we must dig into how Float introduced a whole new industry standard for nurse retention, reaching the mark of 68%, 50% higher than the industry average of 18%.
The reason behind that is rooted in how, while other gig work platforms for nurses jeopardize quality of care and leave nurses unprepared to enter an unfamiliar hospital, Float’s marketplace model for specialty pharma is seemingly well-equipped to offer competitive pay and more customizable schedules.
Apart from that, the company has also formalized well over 100 partnerships with specialty pharmacies. This means Float’s customers presently include some of the biggest names in specialty medicine, such as Optum, CVS, Option Care, Alliance RX (Walgreens), Kroger, and more
In case that wasn’t enough, the company now plans to partner with 20 new specialty pharmacies during Q2 2025. Alongside that, Float will also expand its operations to serve the state of Florida, where a shortage of approximately 60,000 nurses is projected by 2035.
“From the chronic illness patient who can’t risk being in a hospital full of sick people to access quality care, to the specialty pharmacy looking to offload nurse management and reduce operational costs, Float’s recent momentum underscores our commitment to improving healthcare for all through better healthcare technology,” said Ryan Johnson, co-founder and CEO, Float. “Quality patient care and nurse well-being will continue to serve as our North Star as we advance our AI-powered platform to shape the future of home infusion care and gig work while providing pharmacies with a tangible way to retain patients and boost revenue.”
